Beckman Coulter Files for Resale of $600M in 2.5 Percent Convertible Notes | GenomeWeb
NEW YORK (GenomeWeb News) - Beckman Coulter has filed a registration statement with the US Securities and Exchange Commission for the resale of $600 million in 2.5 percent convertible senior notes due 2036. The registration allows holders to resell the securities with certain conditions.
 
The company said it will not receive any proceeds from the resale of the securities by the selling holders.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.